LeMaitre Vascular Acquires Artegraft

Arterex Acquires Adroit USA Inc.

February 3, 2025

Medical Devices

Arterex has acquired Adroit USA Inc., a vertically integrated medical device contract manufacturer with facilities in Bangalore, India and a U.S. engineering lab in Milpitas, California. The deal adds over 650 employees and expanded injection molding, precision metal fabrication and assembly capabilities, strengthening Arterex’s global manufacturing footprint and offering an alternative production source to China.

Integra LifeSciences Acquires ACell, Inc.

December 16, 2020

Medical Devices

Integra LifeSciences agreed to acquire regenerative-medicine company ACell, Inc. for $300 million upfront in cash plus up to $100 million in revenue-based milestones. The acquisition adds ACell's MatriStem porcine urinary bladder matrix platform to Integra's tissue technologies portfolio and is expected to close in Q1 2021, subject to customary conditions.

Solventum Acquires Acera Surgical

December 23, 2025

Medical Devices

Solventum (NYSE: SOLV) has completed the acquisition of Acera Surgical, a privately held bioscience company that develops synthetic tissue matrices for regenerative wound care, for $725 million upfront plus up to $125 million in contingent payments. The deal expands Solventum's MedSurg and advanced wound care portfolio with Acera's synthetic electrospun matrix technology; Acera is expected to generate about $90 million in sales in 2025.

BioVentrix Acquires MateraCor, Inc.

January 27, 2022

Medical Devices

BioVentrix, a privately held medical device company focused on less invasive left-ventricle therapies, has acquired MateraCor, Inc., a Southern California start-up developing an injectable alginate-based hydrogel and delivery system (TCMR) to prevent and reverse heart failure. The deal expands BioVentrix’s product portfolio for left ventricular restoration and adds development expertise as the company builds a platform of complementary heart-failure therapies.

Lectra to Acquire Gerber Technology

February 8, 2021

Industrial Services

Lectra entered into a Memorandum of Understanding to acquire all capital and voting rights of US-based Gerber Technology, subject to work council consultation, merger control clearance and shareholder approval. The proposed deal envisages an upfront cash-free / debt-free payment of €175 million plus 5 million newly issued Lectra shares to AIPCF VI LG (an affiliate of American Industrial Partners), representing a total consideration of about €300 million based on Lectra's Feb 5, 2021 share price; Gerber reported €165 million of revenue in 2020.

Haemonetics Acquires Vivasure Medical

January 11, 2026

Medical Devices

Haemonetics Corporation has acquired Galway-based Vivasure Medical in a transaction valued at up to €185 million, consisting of an upfront €100 million payment plus up to €85 million in contingent milestone payments. The acquisition adds Vivasure's PerQseal Elite fully bioabsorbable vascular closure system to Haemonetics' large-bore closure portfolio; Vivasure has CE Mark approvals and has submitted a PMA to the U.S. FDA.